Education and Training
MD - University of Athens School of Health Sciences, Greece
Pediatrics - SUNY Downstate Medical Center, Brooklyn, NY
Infectious Diseases - Children's Hospital of Philadelphia, Philadelphia, PA
Titles and Academic Titles
Departments and Services
C, D., & Zhang, D., & Stashko, M., & Vasileiadi, E., & Parker, R., & Minson, KA., & Huey, MG., & Huelse, J., & Hunter, D., & Gilbert, TSK., & Norris-Drouin, J., & Miley, M., & Herring, LE., & Graves, LM., & DeRyckere, D., & Earp, HS., & Graham, DK. Data-Driven Construction of Antitumor Agents with Controlled Polypharmacology. Journal of Medicinal Chemistry. (2019); 141(39): 15700-15709. Cited in PubMed; PMID: 31497954.
McDaniel, N.K., & Cummings, T.K., & Iida, M., & Hulse, J., & Pearson, H.E., & Vasileiadi, E., & Parker, R.E., & Orbuch, R.A., & Ondracek, O.J., & Welke, N.B., & Kang, G.H., & Davies, K.D., & Wang, X., & DeRyckere, D., & Graham D.K., & Wheeler D.K. MERTK mediates intrinsic and adaptive resistance to AXL-targeting agents. Molecular Cancer Therapeutics. (2018); 17(11): 2297-2308. Cited in PubMed; PMID: 30093568.
Smart, S.K., & Vasileiadi, E., & Wang, X., & DeRyckere, D., & Graham, DK. The Emerging Role of TYRO3 as a Therapeutic Target in Cancer. Cancers (Basel). (2018); 10(12): 474.Cited in PubMed; PMID: 30501104.
Zhao, J., & Zhang, D., & zhang, w., & Stashko, M., & DeRyckere, D., & Vasileiadi, E., & Parker, R., & Hunter, D., & Liu, Q., & Zhang, Y., & Norris-Drouin, J., & Drewry, D., & Kireev, D., & Graham, D., & Earp, H., & Frye, S.V., & Wang, X. Highly selective MERTK inhibitors achieved by a single methyl group. Journal of Medicinal Chemistry.(2018); 61(22): 10242-10254. Cited in PubMed; PMID: 30347155.
Posters and Presentations
Maldonado, JE., & Vasileiadi, E., & Mehta, S., & Sitt, H. (2021, April). Single Growth Curve for Newborn Weight Classification at Birth in the Nursery. Poster presented at: 2021 Downstate Research Colloquium; Brooklyn, NY.
Minson, KA., & Vasileiadi, E., & Madeline, GH., & Wang, X., & Frye, SV., & Earp, HS., & DeRyckere, D., & Graham, DK. (2019, March). Stromal cell activation of MAPK signaling pathways mediates resistance to MERTK inhibition in acute myeloid leukemia. Post er presented at: Proceedings of the American Association for Cancer Research Annual Meeting 2019; Atlanta, GA.
Summers, RJ., & Minson, KA., & Vasileiadi, E., & Wang, Xiadong., & Frye, SV., & Earp, HS., & DeRyckere, D., & Graham, DK. (2019, March). MERTK and BCL-2 as potential therapeutic targets in early T-precursor acute lymphoblastic leukemia. Poster presented at: Proceedings of the American Association for Cancer Research Annual Meeting ; Atlanta, GA.
Leadership and Memberships
Memberships in Professional Organizations
Athens Medical Association
American Academy of Pediatrics
American Medical Association
Patient Experience Ratings
About the Patient Experience Rating System
The Patient Experience Rating is an average of all responses to the care provider related questions shown above from our nationally-recognized Press Ganey Patient Satisfaction Survey. Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question.
Responses are measured on a scale of 1 to 5 with 5 being the best score.
We are committed to true transparency. However, to ensure the comments are fair and correctly attributed, we review each one before posting to the website. We exclude entire comments that disclose patient's protected health information, are off-topic, or include other confidential or inappropriate content. Comments will appear on provider bios only if providers have a minimum number of comments.
Comments are shared internally for education purposes to ensure that we are doing our very best for the patients and families for whom we are privileged to care.
The comments are submitted by patients and families and reflect their views and opinions. The comments are not endorsed by and do not reflect the views of Children’s Hospital of Philadelphia.